OUTCOME OF EPISURF MEDICAL’S RIGHTS ISSUE
The subscription period for Episurf Medical’s new issue of A and B shares with preferential right for the company’s shareholders ended on 13 March 2017 and the final outcome shows that the rights issue was subscribed for by shareholders to approximately 91.5 per cent, which means that Episurf Medical receives approximately SEK 109.5 million before issue related costs. In accordance with the resolution of the shareholders’ meeting on 20 February 2017, which approved the board of directors’ resolution on a new issue of A and B shares with preferential rights for the Company’s shareholders,